...
机译:Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
Yale Department of Psychiatry Yale School of Medicine;
Department of Psychiatry Zucker Hillside Hospital;
CNS NetworkCerevel Therapeutics;